2018
DOI: 10.3892/ol.2018.8342
|View full text |Cite
|
Sign up to set email alerts
|

Activation of FXR promotes intestinal metaplasia of gastric cells via SHP‑dependent upregulation of the expression of CDX2

Abstract: Gastric intestinal metaplasia (IM) induced by bile acid is a precancerous lesion of gastric adenocarcinoma and is associated with the expression of caudal-related homeobox 2 (CDX2). In the present study, the role of farnesoid X receptor (FXR) on the regulation of CDX2 in gastric cells was investigated and the underlying molecular mechanisms were examined. Human gastric cell lines were treated with chenodeoxycholic acid (CDCA) or FXR agonist GW4064. Cells were treated with CDCA in the presence or absence of the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
30
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
4
3
1

Relationship

5
3

Authors

Journals

citations
Cited by 22 publications
(31 citation statements)
references
References 30 publications
1
30
0
Order By: Relevance
“…Now, the mechanism of the transformation from normal gastric mucosal cells to intestinal cells is not clear. It is widely accepted that IM is the result of the interaction of a series of intestine related transcription factors and CDX2 plays an indispensable role in stimulating intestinal differentiation [22][23][24][25][26][27]. Recently, what attracts people's attention is the regulatory mechanism of CDX2 in intestinal differentiation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Now, the mechanism of the transformation from normal gastric mucosal cells to intestinal cells is not clear. It is widely accepted that IM is the result of the interaction of a series of intestine related transcription factors and CDX2 plays an indispensable role in stimulating intestinal differentiation [22][23][24][25][26][27]. Recently, what attracts people's attention is the regulatory mechanism of CDX2 in intestinal differentiation.…”
Section: Discussionmentioning
confidence: 99%
“…found that upregulation of CDX2 and MUC2 in BA-induced gastric IM cells resulted from activated FXR/NF-κB pathway [21]. Similarly, one of our previous studies found that FXR is responsible for the enhancement of CDX2 by a SHP-dependent way in gastric cells [22]. However, the study on the mechanisms of FXR promotes BA-induced gastric IM is still far from enough.…”
Section: Introductionmentioning
confidence: 87%
“…However, it is ectopically expressed in IM lesions of the stomach and intestinal-type gastric carcinoma [1][2][3][4][5][6][7][8]. Several studies have reported that CDX2 acts as a tumor suppressor in gastric cancer [6][7][8][21][22][23][24][25][26][27][28][29][30][31].…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have reported that CDX2 acts as a tumor suppressor in gastric cancer [6][7][8][21][22][23][24][25][26][27][28][29][30][31]. However, others consider CDX2 an oncogene in gastric cancer [1,2,[9][10][11][12][13][14][15][16][17][18][19][20]. These contradictory ndings imply that CDX2 plays a complex regulatory role in gastric cancer.…”
Section: Discussionmentioning
confidence: 99%
“…The role of FXR is more controversial, or complex. FXR was demonstrated to be involved in the bile-acid dependent progression of intestinal metaplasia (37), possibly through a SHPdependent increase of CDX2 gene expression (38). In contrast, the deletion or downregulation of FXR favors hepatocarcinogenesis (27,39), suggesting that FXR plays a protective role.…”
Section: Discussionmentioning
confidence: 99%